Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment
GE
ABT
ABT, ERIC, IVZ
AMAT, GOOGL, ANET, AAPL, CVX, ADI, AXON, URI, COST, V, LLY, SPGI, PANW, META, NVDA, SYK, BSX, ORCL, CBOE, PWR, MCK, NOW, LYFT, ADBE, SCHW, MCHP, ISRG, AMZN, CRM, ODFL
TFC, OMC, VZ, GILD, TSM
Damien Conover
Sector Director